KISTOSYN
LIVE

Serial Number

79211856

Owner

Ceres Pharma Hungary Kft.

Filing Date

Jan 3, 2017

Add to watchlist:

No watchlists yet
View on USPTO

KISTOSYN Trademark

Serial Number: 79211856 • Registration: 5597954

KISTOSYN is a trademark filed by Ceres Pharma Hungary Kft. on January 3, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Ceres Pharma Hungary Kft. (2 trademarks)

Dunavirág utca 2-6. 1. ép. 5. em.

Entity Type: 98

Trademark Details

Filing Date

January 3, 2017

Registration Date

November 6, 2018

Published for Opposition

August 21, 2018

Cancellation Date

May 23, 2025

Goods & Services

Aldehydes for pharmaceutical purposes; alginate dietary supplements; aloe vera preparations for pharmaceutical purposes; amino acids for medical purposes; anti-oxidant food supplements; antioxidant enriched coffee for medical purposes; antibiotics; antibiotics for human use; mineral food supplements; food supplements in the nature of anti-oxidants in pill form; mineral waters for medical purposes; asthmatic tea; bacteriological preparations for medical and veterinary use; cultures of microorganisms and biological tissue cultures all for medical and veterinary use; bacterial poisons; bacterial preparations for medical and veterinary use; medicinal diaper rash ointments; medicinal ointments for treating dermatological conditions; balms for medical purposes; gurjun balsam preparations for medical purposes; mixed biological preparations for the prevention and treatment of infectious diseases for both medical and veterinary purposes; medicated skin care lotions; skin care creams for medical use; wheat germ dietary supplements; melissa water for pharmaceutical purposes; gallic acid for pharmaceutical purposes; stick liquorice for pharmaceutical purposes; medicinal herbs in the nature of fennel; dietary fiber to aid digestion; dietary fiber for treating constipation; yeast for pharmaceutical purposes; yeast dietary supplements; yeast extracts for pharmaceutical purposes; pharmaceutical preparations, namely, elixirs for the treatment of viral and bacterial infections; enzymes for medical purposes; enzyme preparations for medical purposes; cardiotonics; enzyme dietary supplements; expectorants composed of eucalyptol; eucalyptus for pharmaceutical purposes; sterilising preparations; disinfectants; disinfectants and antiseptics; germicides; disinfectants other than disinfectant soap; disinfectants for medical instruments; fumigants; glucose for medical purposes; dietetic by-products of the processing of cereals adapted for medical purposes; glucose dietary supplements; glucose preparations for medical purposes; fungicides; fungicides for medical use; biological fungicides; fungal extracts sold as a component ingredient of nutritional supplements and vitamins; medicinal tea; medicinal drinks; medicinal herbs; medicated candy; extracts of medicinal herbs; herbal teas for medicinal purposes; nutritionally fortified herbal beverages for medical purposes; medicinal herbal extracts for medical purposes; pharmaceutical preparations for the treatment of respiratory diseases; medicated lozenges; sugar-coated medicated lozenges; medicated food supplements; herbal extracts for medical purposes; plant extracts for medical purposes; herbal pills for the treatment of diabetes; natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; medicinal herbal preparations; rhubarb roots for pharmaceutical purposes; aloe vera preparations for pharmaceutical purposes; medicinal herbs for smoking cessation; herbal teas for medicinal purposes; urinary tract disinfectants; anti-uric preparations; vaginal washes for medical purposes; douching preparations for medical purposes; pharmaceutical preparations and substances for the treatment of damaged skin and tissue featuring irish moss; iodine; iodine for pharmaceutical purposes; potassium, sodium and silver iodides for pharmaceutical purposes; camphor oil for medical purposes; camphor for medical purposes; candy for medical purposes; dill oil for medical purposes; capsules sold empty for pharmaceuticals; parasiticides; disposable wipes impregnated with pharmaceutical lotions; disposable wipes impregnated with disinfecting chemicals or compounds therefor for use on plastic and metal surface objects; disposable wipes impregnated with disinfecting chemicals or compounds therefor for use in households, vehicles, hotels and hospitals; pre-moistened medicated wipes; ointments for pharmaceutical purposes; sulfur sticks as disinfectants; flowers of sulfur for pharmaceutical purposes; angostura bark for medical purposes; mangrove bark for pharmaceutical purposes; quebracho bark for medical use; condurango bark for medical purposes; croton bark for medical purposes; collodion for pharmaceutical purposes; extracts of hops for pharmaceutical purposes; air purifying preparations; disinfectant washes for sanitary purposes; sanitary sterilizing preparations in the nature of washes; royal jelly for pharmaceutical purposes; royal jelly dietary supplements; mint for pharmaceutical purposes; menthol for pharmaceutical purposes; mentholated ointment for medical use; mustard poultices for pharmaceutical purposes; medicated body powder composed of mustard; mustard oil for medical purposes; medicinal herb preparations composed of mustard; medicinal roots; myrobalan barks for pharmaceutical purposes; prescription and non-prescription medicines, namely, capsules and pharmaceutical preparations for the treatment of cardiovascular disorders; medicinal oils; medicated lozenges for the treatment of respiratory diseases; cough lozenges for medical use; pollen dietary supplements; propolis for pharmaceutical purposes; propolis dietary supplements; chewing gum for medical purposes; medicated bath salts; medicated mouthwash; mouthwashes for medical purposes; gargles for medical purposes; medicated anti-cavity mouth spray; medicated dental rinse; antiseptic mouthwashes; medicated mouthwashes, namely, antimicrobial mouthwashes; medicated serums for the treatment of the mouth and throat; syrups for pharmaceutical purposes for the treatment of the mouth for disinfection and for the treatment of respiratory diseases; tinctures of iodine for medical purposes; detergents for medical purposes; vaccines; vitamin tablets; vitamin preparations; vitamin supplements; vitamin supplement in tablet form for use in making an effervescent beverage when added to water; mixed vitamin preparations; gelatin capsules sold empty for pharmaceuticals; fumigation preparations for medical purposes; gurjun balsam for medical purposes; bronchodilating preparations

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 23, 2026 INTR
CANCELLED SECTION 71
May 23, 2025 C71T
CHANGE OF OWNER RECEIVED FROM IB
Feb 8, 2025 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2019 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Feb 10, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 9, 2019 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 6, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 6, 2018 R.PR
PUBLISHED FOR OPPOSITION
Aug 21, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Aug 17, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 1, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 1, 2018 OP2R
NOTICE OF PUBLICATION
Aug 1, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2018 CNSA
EXAMINERS AMENDMENT MAILED
Jul 16, 2018 CNEA
EXAMINER'S AMENDMENT ENTERED
Jul 14, 2018 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jul 14, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 9, 2018 ERFR
FINAL REFUSAL MAILED
Jan 12, 2018 CNFR
FINAL REFUSAL WRITTEN
Jan 11, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2017 CRFA
ASSIGNED TO LIE
Dec 21, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 14, 2017 TROA
REFUSAL PROCESSED BY IB
Aug 4, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 20, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jul 20, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Jul 18, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 14, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jul 13, 2017 CNRT
ASSIGNED TO EXAMINER
Jul 12, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 6, 2017 REPR